(Q37222365)

19 August 2017

1 reference

title

Somatostatin and dopamine receptors as targets for medical treatment of Cushing's Syndrome (English)

1 reference

19 August 2017

0 references

C de Bruin

1

1 reference

19 August 2017

R A Feelders

series ordinal

2

1 reference

19 August 2017

S W J Lamberts

series ordinal

3

1 reference

19 August 2017

L J Hofland

series ordinal

4

1 reference

19 August 2017

language of work or name

1 reference

19 July 2008

1 reference

Reviews in Endocrine and Metabolic Disorders

19 August 2017

published in

1 reference

19 August 2017

volume

10

1 reference

19 August 2017

issue

2

1 reference

19 August 2017

page(s)

91-102

1 reference

Failure of somatostatin and octreotide to acutely affect the hypothalamic-pituitary-adrenal function in patients with corticotropin hypersecretion

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11154-008-9082-4

Long-term treatment of Nelson's syndrome by octreotide: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-008-9082-4

Dopamine actions on calcium currents, potassium currents and hormone release in rat melanotrophs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-008-9082-4

Effect of cabergoline treatment on Cushing's disease caused by aberrant adrenocorticotropin-secreting macroadenoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-008-9082-4

Is there a therapeutic role for octreotide in patients with ectopic Cushing's syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-008-9082-4

Release of pro-opiomelanocortin-derived peptides from the pars intermedia and pars distalis of the rat pituitary: effect of corticotrophin-releasing factor and somatostatin

21 January 2018

1 reference

12 December 2020

Native somatostatin sst2 and sst5 receptors functionally coupled to Gi/o-protein, but not to the serum response element in AtT-20 mouse tumour corticotrophs

1 reference

12 December 2020

Inhibition of Adrenocorticotropin Secretion by Somatostatin in Pituitary Cells in Culture*

1 reference

12 December 2020

Expression and localization of human dopamine D2 and D4 receptor mRNA in the adrenal gland, aldosterone-producing adenoma, and pheochromocytoma

1 reference

12 December 2020

Induced expression of the glucocorticoid receptor in the rat intermediate pituitary lobe

1 reference

12 December 2020

The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5.

1 reference

12 December 2020

Somatostatin receptor-specific analogs: effects on cell proliferation and growth hormone secretion in human somatotroph tumors

1 reference

12 December 2020

Nelson's syndrome: complete remission with cabergoline but not with bromocriptine or cyproheptadine treatment.

1 reference

12 December 2020

Adrenocorticotropin-Secreting Pituitary Adenomas Originate from the Anterior or the Intermediate Lobe in Cushing's Disease: Differences in the Regulation of Hormone Secretion

1 reference

12 December 2020

Induction of apoptosis in murine ACTH-secreting pituitary adenoma cells by bromocriptine

1 reference

12 December 2020

Dopaminergic inhibition of pituitary beta-endorphin-like immunoreactivity secretion in the rat.

1 reference

12 December 2020

Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. II. Agonist and antagonist properties at subtypes of dopamine D(2)-like receptor and alpha(1)/alpha(2)-adrenoceptor

1 reference

12 December 2020

Dopamine receptor expression and function in clinically nonfunctioning pituitary tumors: comparison with the effectiveness of cabergoline treatment

1 reference

12 December 2020

Effect of Sandostatin on CRF-Stimulated Secretion of ACTH, β-Lipotropin and β-Endorphin

1 reference

12 December 2020

Repeated transsphenoidal surgery to treat recurrent or residual pituitary adenoma

1 reference

12 December 2020

Bim-23244, a somatostatin receptor subtype 2- and 5-selective analog with enhanced efficacy in suppressing growth hormone (GH) from octreotide-resistant human GH-secreting adenomas

1 reference

12 December 2020

Distinct functional properties of native somatostatin receptor subtype 5 compared with subtype 2 in the regulation of ACTH release by corticotroph tumor cells.

1 reference

12 December 2020

Cabergoline plus lanreotide for ectopic Cushing's syndrome

1 reference

12 December 2020

Central Nervous System Regulation of Adrenocorticotropin Secretion: Role of Somatostatins*

1 reference

12 December 2020

Octreotide exerts different effects in vivo and in vitro in Cushing's disease

1 reference

12 December 2020

Inhibition by somatostatin of ACTH secretion in Nelson's syndrome

1 reference

12 December 2020

Pituitary radiotherapy

1 reference

12 December 2020

Dopamine receptor expression and function in corticotroph ectopic tumors.

1 reference

12 December 2020

SOM230: a new somatostatin peptidomimetic with potent inhibitory effects on the growth hormone/insulin-like growth factor-I axis in rats, primates, and dogs

1 reference

12 December 2020

Glucocorticoid receptor structure and function in an adrenocorticotropin-secreting small cell lung cancer

1 reference

12 December 2020

Absence of dopaminergic control on melanotrophs leads to Cushing's-like syndrome in mice

1 reference

12 December 2020

Functional activity of the multiligand analog SOM230 at human recombinant somatostatin receptor subtypes supports its usefulness in neuroendocrine tumors

1 reference

12 December 2020

[Nelson's syndrome management: current knowledge]

1 reference

12 December 2020

Bromocriptine inhibits pro-opiomelanocortin mRNA and ACTH precursor secretion in small cell lung cancer cell lines

1 reference

12 December 2020

Valvular heart disease and the use of dopamine agonists for Parkinson's disease

1 reference

12 December 2020

The Effects of SOM230 on Cell Proliferation and Adrenocorticotropin Secretion in Human Corticotroph Pituitary Adenomas

1 reference

12 December 2020

Dopamine receptor expression and function in corticotroph pituitary tumors

1 reference

12 December 2020

A role of (labeled) somatostatin analogs in the differential diagnosis and treatment of Cushing's syndrome

1 reference

12 December 2020

Dopamine agonists and the risk of cardiac-valve regurgitation

1 reference

12 December 2020

Somatostatin and dopamine-somatostatin multiple ligands directed towards somatostatin and dopamine receptors in pituitary adenomas

1 reference

12 December 2020

The pituitary-adrenal response to CRF-41 is unaltered by intravenous somatostatin in normal subjects

1 reference

12 December 2020

Studies on the conditions determining the inhibitory effect of somatostatin on adrenocorticotropin, prolactin and thyrotropin release by cultured rat pituitary cells

1 reference

12 December 2020

Differential expression of the human somatostatin receptor subtypes sst1 to sst5 in various adrenal tumors and normal adrenal gland

1 reference

12 December 2020

Combined therapy of somatostatin analogues and dopamine agonists in the treatment of pituitary tumours

1 reference

12 December 2020

Somatostatin receptor subtypes 2 and 5 inhibit corticotropin-releasing hormone-stimulated adrenocorticotropin secretion from AtT-20 cells

1 reference

12 December 2020

Complete remission of Nelson's syndrome after 1-year treatment with cabergoline

1 reference

12 December 2020

Dose-response study of the inhibiting effect of somatostatin on growth hormone and insulin secretion in normal subjects and acromegalic patients

1 reference

12 December 2020

Somatostatin receptors in human endocrine tumors

1 reference

12 December 2020

Pasireotide (SOM230): development, mechanism of action and potential applications

1 reference

12 December 2020

The effect of the long-acting somatostatin analogue SMS 201-995 on ACTH secretion in Nelson's syndrome and Cushing's disease

1 reference

12 December 2020

Clinical and biochemical stabilization of Nelson's syndrome with long-term low-dose cabergoline treatment

1 reference

12 December 2020

Efficacy of chimeric molecules directed towards multiple somatostatin and dopamine receptors on inhibition of GH and prolactin secretion from GH-secreting pituitary adenomas classified as partially responsive to somatostatin analog therapy.

1 reference

12 December 2020

Immunohistochemical localization of somatostatin receptor subtypes in benign and malignant adrenal tumours.

1 reference

12 December 2020

Somatostatin and dopamine receptor expression in lung carcinoma cells and effects of chimeric somatostatin-dopamine molecules on cell proliferation.

1 reference

12 December 2020

The role of somatostatin in the regulation of anterior pituitary hormone secretion and the use of its analogs in the treatment of human pituitary tumors

1 reference

12 December 2020

Dopamine D2 receptor gene expression in human adenohypophysial adenomas

1 reference

12 December 2020

Heart valve disease associated with treatment with ergot-derived dopamine agonists: a clinical and echocardiographic study of patients with Parkinson's disease

1 reference

12 December 2020

The somatostatin analog SMS 201-995 induces long-acting inhibition of growth hormone secretion without rebound hypersecretion in acromegalic patients

1 reference

12 December 2020

Ketoconazole revisited: a preoperative or postoperative treatment in Cushing's disease

1 reference

12 December 2020

Dopaminergic receptor mechanisms modulating the renin-angiotensin system and aldosterone secretion: an overview.

1 reference

12 December 2020

Somatostatin and Somatostatin Receptor Physiology

1 reference

12 December 2020

Pharmacological characterization and autoradiographic localization of dopamine receptors in the human adrenal cortex

1 reference

12 December 2020

Action of growth-hormone-release inhibitory hormone in healthy men and in acromegaly

1 reference

12 December 2020

The medical management of Cushing's syndrome

1 reference

12 December 2020

Pharmacological characterisation of native somatostatin receptors in AtT-20 mouse tumour corticotrophs

1 reference

12 December 2020

BIM-23A760, a chimeric molecule directed towards somatostatin and dopamine receptors, vs universal somatostatin receptors ligands in GH-secreting pituitary adenomas partial responders to octreotide

1 reference

12 December 2020

Incidence and Late Prognosis of Cushing’s Syndrome: A Population-Based Study1

1 reference

12 December 2020

Clinical review: the strategy of immediate reoperation for transsphenoidal surgery for Cushing's disease

1 reference

12 December 2020

Widespread distribution of somatostatin receptor messenger ribonucleic acids in rat pituitary

1 reference

12 December 2020

The Role of Somatostatin and Its Analogs in the Diagnosis and Treatment of Tumors

1 reference

12 December 2020

Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance

1 reference

12 December 2020

The role of somatostatin analogs in Cushing's disease

1 reference

12 December 2020

ACTH silent adenoma shrinking under cabergoline.

1 reference

12 December 2020

Cell specific expression of the sst2A and sst5 somatostatin receptors in the rat anterior pituitary

1 reference

12 December 2020

Gamma Knife surgery for Cushing's disease

1 reference

12 December 2020

Dopamine receptor expression and function in human normal adrenal gland and adrenal tumors

1 reference

12 December 2020

1 reference

12 December 2020

[Use of cabergoline in persisting Cushing's disease]

1 reference

12 December 2020

Pharmacokinetic-pharmacodynamic comparison of a novel multiligand somatostatin analog, SOM230, with octreotide in patients with acromegaly

1 reference

12 December 2020

The Medical Treatment of Cushing's Syndrome

1 reference

12 December 2020

The effect of SMS 201-995, a long-acting somatostatin analogue, on anterior pituitary function in healthy male volunteers

1 reference

12 December 2020

Suppression of ectopic adrenocorticotropin secretion by the long-acting somatostatin analog octreotide

1 reference

12 December 2020

1 reference

12 December 2020

The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitro

1 reference

12 December 2020

SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile

1 reference

12 December 2020

Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity

1 reference

12 December 2020

Somatostatin and its receptor family

1 reference

12 December 2020

Is there a role for somatostatin and its analogs in Cushing's syndrome?

1 reference

12 December 2020

Human small cell lung cancer cell lines expressing the proopiomelanocortin gene have aberrant glucocorticoid receptor function

1 reference

12 December 2020

Immunohistochemical determination of somatostatin receptor subtypes 1, 2A, 3, 4, and 5 in various adrenal tumors

1 reference

12 December 2020

Long-term treatment of acromegaly with the somatostatin analogue SMS 201-995.

1 reference

12 December 2020

Bromocriptine as primary therapy for prolactin-secreting macroadenomas: results of a prospective multicenter study

1 reference

12 December 2020

Glucocorticoids Down-Regulate Somatostatin Receptors on Pituitary Cells in Culture*

1 reference

12 December 2020

Expression of mRNA for somatostatin receptor (sstr) types 2 and 5 in individual rat pituitary cells. A double labeling in situ hybridization analysis

1 reference

12 December 2020

Dopamine receptors: from structure to function

1 reference

12 December 2020

The effects of octreotide in a patient with Nelson's syndrome

1 reference

12 December 2020

Successful treatment with SMS 201-995 of Cushing's syndrome caused by ectopic adrenocorticotropin secretion from a metastatic gastrin-secreting pancreatic islet cell carcinoma

1 reference

12 December 2020

Additive effect of ketoconazole and octreotide in the treatment of severe adrenocorticotropin-dependent hypercortisolism

1 reference

12 December 2020

The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up.

1 reference

12 December 2020

Medical therapy of Cushing's disease

1 reference

12 December 2020

Radiation therapy for Cushing's disease: a review

1 reference

12 December 2020

Somatostatin receptor subtypes SSTR2 and SSTR5 couple negatively to an L-type Ca2+ current in the pituitary cell line AtT-20.

1 reference

12 December 2020

Bromocriptine-responsive Cushing's disease associated with anterior pituitary corticotroph hyperplasia or normal pituitary gland

1 reference

12 December 2020

The pathophysiological consequences of somatostatin receptor internalization and resistance

1 reference

12 December 2020

Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone

1 reference

12 December 2020

Somatostatin analogs for the localization and preoperative treatment of an adrenocorticotropin-secreting bronchial carcinoid tumor

1 reference

12 December 2020

Cushing's syndrome due to ectopic corticotropin secretion: twenty years' experience at the National Institutes of Health

1 reference

12 December 2020

Novel insights in dopamine receptor physiology

1 reference

12 December 2020

Somatostatin: A potent inhibitor of ACTH-Hypersecretion in adrenal insufficiency

1 reference

12 December 2020

The Mechanism of the Suppressive Action of Bromocriptine on Adrenocorticotropin Secretion in Patients with Cushing′s Disease and Nelson′s Syndrome*

1 reference

12 December 2020

1 reference

12 December 2020

Somatostatin receptor scintigraphy: its value in tumor localization in patients with Cushing's syndrome caused by ectopic corticotropin or corticotropin-releasing hormone secretion

1 reference

12 December 2020

Incidence and late prognosis of cushing's syndrome: a population-based study

1 reference

12 December 2020

10.1007/S11154-008-9082-4

Identifiers

DOI

1 reference

19 August 2017

1 reference